Posted by AGORACOM
at 3:09 PM on Tuesday, October 26th, 2021
AI/ML Innovations is capitalizing on the burgeoning areas of artificial intelligence (AI), cloud computing and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space.
Its key subsidiary, Health Gauge, is a leading digital health solutions provider that’s disrupting the traditional healthcare industry by providing AI innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure.
Its patent-pending solution is a bespoke personal health monitoring and management system, combining the latest wearable health monitors with sophisticated software tools.
Health Gauge provides for a secure and trusted means for clients to engage clinical resources and health coaching as a regular part of their care process and ongoing health management. Its robust, real-time data capture capability provides fast feedback, resulting in better recovery outcomes and healthy living objectives through the ability to make immediate and better health choices.
In addition to Health Gauge, AI/ML also has a strategic partner in Tech2Heal, a France-based global provider of proprietary digital mental health and wellness products.
In late September, AI/ML announced that it had completed its transaction to acquire a significant interest in Tech2Heal (dba Tech2Health), and that Tech2Heal was readying its remote patient monitoring platform for deployment.
Now, AI/ML Innovations & Tech2Heal’s AI Rx joint venture is preparing for imminent launch into the U.S. market, with a basket of wellness and health-tech products and services designed to improve an individual’s mental health and well-being, and utilizing a unique blend of proprietary digital assets, remote live counselling, and a physical wellness center.
We caught up with Tim Daniels, AI/ML’s Executive Chairman, to discuss the firm’s progress…
In this episode of the podcast, Dr. Steve Thayer and Dr. Reid Robison are joined for the second time by Dr. Paul Thielking, MD. He is a psychiatrist, zen practitioner, and Chief Scientific Officer at Novamind.
Chief Scientific Officer, Dr. Paul Thielking speaks with Amanda Siebert from The Dales Report on the potential of psychedelics for palliative care and the role of group therapy.
Chief Medical Officer, Dr. Reid Robison discusses Novamind being granted DEA licenses for psilocybin research and our new Psychedelic Palliative Care program with AGORACOM.
Dr. Reid Robison opened the PSYCH Investor Summit with a keynote address presenting Novamind’s positioning and the rise and rollout of psychedelic medicine.
We are pleased to announce we have been granted Schedule 1 licenses (the “DEA Licenses”) from the U.S. Drug Enforcement Agency (DEA) for Dr. Reid Robison, Chief Medical Officer, and Dr. Paul Thielking, Chief Scientific Officer. The DEA Licenses are required for research sites planning to host clinical trials for psilocybin, enabling principal investigators to store and administer this controlled substance.
“Obtaining the DEA Licenses is a critical step towards hosting clinical trials for psilocybin-assisted psychotherapy,” commented Dr. Robison. “We’re proud of our clinical research organization’s track record investigating innovative solutions for central nervous system conditions. This milestone reflects our expertise and enables us to continue on our mission to create breakthroughs in mental health treatment.”
Psilocybin has shown significant positive outcomes for people with major depressive disorder¹ and for reducing anxiety and depression in people with life-threatening cancer.² As of today, there are over 50 clinical studies actively examining the use of psilocybin, as listed on www.clinicaltrials.gov.
“The DEA Licenses are timely,” said Dr. Thielking, who last week launched Psychedelic Palliative Care by Novamind, a first of its kind program to support the mental health of patients and families struggling with serious illness. “We anticipate that this progress will accelerate the approval process for us to become a research site for additional psychedelic clinical studies in the future.”
Time magazine writes how the burnout, trauma and stress caused by the COVID-19 pandemic is opening the door to accelerated psychedelic research. “It’s no coincidence that psychedelics are entering the conversation at the moment we most sorely need new ideas in mental health care. The world is experiencing mass trauma from COVID-19.” It’s especially true with frontline workers. The stats are alarming. The need has never been more apparent. It’s why we launched our Frontline Ketamine-Assisted Psychotherapy treatment program earlier this year. We’re providing healthcare workers with critical mental healthcare. You can learn more about the program here.
Therapeutic Goods Administration (TGA) in Australia is currently evaluating a proposal to reschedule two prominent psychedelics into a less restrictive classification. Mind Medicine Australia submitted the proposal to the government and “has the support of world leading experts in psychedelic research.” Novamind Chief Medical Officer, Dr. Reid Robison, will be presenting at the Mind Medicine Australia summit in November. Get your tickets here.
Could psychedelics follow the same path of cannabis toward legalization and regulation for medical purposes? It’s a question Luis Millán asks for National Magazine. “Despite the legal uncertainty, business is hopeful. Some stock market speculators believe psychedelics will follow in the footsteps of the cannabis industry and become the next billion-dollar business.”
Posted by AGORACOM-JC
at 10:01 AM on Wednesday, October 6th, 2021
12 months ago investors couldn’t be blamed if they found it hard to grasp the genius and foresight of Liquid Avatar $LQID $LQAVF ….. the easiest way to describe the company was as a blockchain platform allowing people to manage & profit from their digital identity, which became a real need once global laws started being enacted to prevent the likes of Facebook from every abusing our private information again.
Moreover, the platform also provides both businesses and governments the ability to easily integrate digital wallets and digital identity solutions through its Liquid Avatar platform (www.liquidavatar.com).
It sounded great … and definitely sounded like something you could see starting to happen 3-4 years into the future … but then the signs started showing up that painted an accelerating picture that would put LQID at the forefront of digital identity.
1. In March of this year, Google validated the $LQID business model with this stunning announcement:
Google believes these types of tracking methods don’t “meet rising consumer expectations for privacy, nor will they stand up to rapidly evolving regulatory restrictions, and therefore aren’t a sustainable long term investment.”
Google is experimenting with tools in its Privacy Sandbox that are designed to allow advertising to continue to work on the web but in a less privacy-encroaching way.
“Keeping the internet open and accessible for everyone requires all of us to do more to protect privacy — and that means an end to not only third-party cookies, but also any technology used for tracking individual people as they browse the web,” David Temkin, Google’s director of product management for ads privacy and trust,
What is the potential outcome of this major shift by Google?
“Google’s decision could upend the ad industry, which has relied on these types of tracking tools”
With this news, the data privacy and monetization game is underway and LQID sitting in a great position within the industry and the dominant position within the small cap world.
BUT THAT’S NOT ALL
2. In May of this year, The Ontario government released its digital identity strategy outlining ways in which it plans to harness the potential of the digital economy and better utilize data. Included in the plan are tangible commitments.
Then came the news all Liquid Avatar investors were waiting for:
the introduction of a new government-issued digital ID that lets people prove who they are both online and in person.
These 2 announcements out of Google and the Ontario Government officially put both business and government in the digital identity and credentials game. There is no looking back.
ENTER LIQUID AVATAR – WORKING WITH ONTARIO GOVERNMENT
Enter $LQID whose Liquid Avatar Verifiable Credentials Ecosystem (LAVCE) is being built to support all participants in a digital credential ecosystem, including the Holder, Issuer and Verifier, using state-of-the-art blockchain and open standards technologies . More than just a good idea, $LQID issued a press release announcing the following:
“Ontario is one of the first jurisdictions in North America to announce that it will issue and enable digital credentials – and it has been a great experience working with the government on this both directly and through our role in membership organizations like the Trust Over IP Foundation”
AND
“Liquid Avatar Technologies has been a part of the ongoing consultations around the province’s plan to introduce a digital identification credential by the end of 2021”
ENTER LIQUID AVATAR – OUT OF DEVELOPMENT AND INTO COMMERCIALIZATION WITH 8,000 CONVENIENCE STORES
This morning $LQID released major news on the commercialization side whose title speaks for itself:
According to CEO Lucatch, this announcement represents a major inflection point as it signals a shift from development to commercialization, with many more potential deals in discussion.
LQID IS THE LEADING SMALL CAP COMPANY IN MASSIVE PARADIGM SHIFT TOWARD DIGITAL IDENTITY, PRIVACY AND MONETIZATION
Make no mistake about it. This is a simply massive paradigm shift and $LQID isn’t going to tackle this on its own. The Company is a voting and steering committee member of the Trust over IP Foundation, founding and steering committee member of Cardea, a Linux Foundation Public Health project, member of the Good Health Pass collaborative, ID2020, DIACC, The Linux Foundation and a founding member of the Lumedic Exchange.
Suddenly it is getting easy to see the genius of Liquid Avatar.
Watch this great interview with CEO David Lucatch.
Posted by AGORACOM
at 4:55 PM on Thursday, September 30th, 2021
MVMD Takes Existing Vaccines and Drugs – And Delivers Them Better. Both Into The Body and By Transportation To The World. Way Better.
For the purposes of introducing you to Mountain Valley MD (MVMD), we’ll use vaccines as an example given the state of the world since COVID-19 arrived. Specifically, we’ve all heard more about vaccines in 12 months than we have in the last 12 years. One thing we all know about vaccines is that vaccination is the safest way to protect people against infectious diseases.
BUT
One thing we don’t know or understand about vaccinations is that they are only as good as:
1. The global physical delivery system that actually gets them from the manufacturer to the hands of nurse who injects the vaccine;
2. The delivery system into your body (i.e. injection)
If either parts of these delivery systems are weak, or even fail, a vaccine loses some or even all of its potency – and that’s not good. This is where MVMD comes in. They don’t make the vaccines, drugs or pharmaceuticals.
What they do is make their delivery better. Their physical delivery until their ultimate delivery into your body – and that is very good. By doing so, they help save lives and they help manufacturers be more profitable – and that is very good for humanity and shareholders.
A “magic bullet” is of little use without a “magic gun” – Mountain Valley MD Is The Magic Gun.
Check out these Trials & Research MVMD is accomplishing with their Vaccine technology to improve our lives:
* Expanding Oncology Work for BreastCancer using Quicksol™ technology applications
* Farm Animal Trials Using Solubilized Ivermectin
* Discovering Immediate Demand for Generic Ivermectin Uses
The latest news Involves utilizing their vaccine technology to address & develop products for the Medical Sleep Market in the U.S. strictly using cannibinoids.
Sit back and enjoy the great interview with President & CEO Dennis Hancock as he explains the developing relationship with Red White & Bloom to create products for the US sleep market.
Posted by AGORACOM-JC
at 12:17 PM on Thursday, September 30th, 2021
HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing high value-added silicon products that are sought after by battery and electric vehicle manufacturers – but nobody has yet delivered – until now.
If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:
How powerful is this Revolutionary & Breakthrough Green Hydrogen? Try “SCALABLE WITH NO LIMITS”
“EBH2 is scalable with no limits. It can power a small domestic generator up to ships, factories, buildings, cryptocurrency mines with high energy consumption and even cities.”
Independent validation of the technology is expected to be complete over the next 60 days. If successful, HPQ proposes to bundle the energy production capability of EBH2 systems with its silicon production to further reduce the environmental footprint of its developing high purity silicon, nano powders, and other Renewable Energy products. Moreover, if successful, EBH2 would provide HPQ with “power plant” capabilities that would allow it to produce its products anywhere on the planet.
If that wasn’t enough HPQ added the following:
“all the while opening up new, and massive addressable markets for a system that can produce cheaply green hydrogen, on demand …. The Agreement establishes the terms of the creation of a new Joint venture Company (“NEWCO”) owned by HPQ and EBH2 that will market, sell and service EBH2 systems and products in North America (Canada, Mexico, and the United States). …. units could readily replace solar panels or standby generators for homeowners.”
Watch this great interview with $HPQ CEO Bernard Tourillon to get the full picture on next steps!
Posted by AGORACOM
at 4:48 PM on Tuesday, September 21st, 2021
Helium is a high tech gas, with many uses in multiple high tech applications:
MRI Magnets, Fibre Optic Cables for High Speed Internet, Airbags, Hard Drives, Chips in our Electronics, Cleaning Rocket Fuel Tanks.
The list is varied and demand is inelastic. They don’t function without Helium and world is in short supply, but Royal Helium is quickly proving that they may be the solution.
They have made a discovery, a big one; and in in just one well, and may have already proven up 500 billion cubic feet of inert gas. One Well. One Zone. Over a Million acres of prospective Helium still to be explored.
Royal Helium aimed to deliver a minimum of 1 trillion cubic feet (Tcf) of total inert gas into the market, and this discovery clearly demonstrates they are on their way. With economic concentrations ranging from 0.33% to 0.94%, Royal has a real possibility of commencing production by the end of the year.
Royal discovered a 40m zone in Climax 3 and tested, cored and recovered the rock to test porosity to see how the gas flows. Expecting to find something similar in Climax 4, they actually found something bigger, much bigger. A zone 120m thick. About the size of twelve story building, containing elevated concentrations of Helium suitable for production. A normal producing area is considered high within a 5 meter range. Royal has a discovery multiples of the global average and they are still very early in their exploration process.
Sit back and enjoy this #SmallCap discovery as Andrew Davidson, CEO & Chairman of Royal Helium RHC: TSXV explains how Royal is putting Saskatchewan on the map with some of the highest historical helium showings while simultaneously developing Climax Nazare without delay or compromise.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by returning guest, Vhari Macbeth to discuss psycholytic ketamine-assisted psychotherapy (KAP).
We are pleased to announce that our wholly owned subsidiary, Cedar Clinical Research has been selected as a research site for a clinical trial sponsored by Karuna Therapeutics, Inc., a clinical-stage neuroscience biopharmaceutical company
The phase III study will evaluate the investigational therapy KarXT for the treatment of schizophrenia, a serious and potentially disabling condition affecting approximately 20 million people worldwide.
Dr. Reid Robison, Novamind’s Chief Medical Officer and Principal Investigator at CCR said, “We need more innovation in this field and I’m hopeful to see compounds like KarXT that have new ways of acting on the brain and the potential for improved efficacy and side effect profiles.”
As psychedelics continue to break free from the stigma surrounding them, more and more people are seeing the promise these drugs have in changing the way we treat mental health. “Recent trials are showing that psychedelics are proving not only successful but also incredibly effective when stacked up against traditional forms of treatment, with one recent trial reporting that they are up to four times more effective than antidepressants.”
In a big step forward for psychedelic research, the DEA is set to increase limits for psilocybin. From the DEA: “DEA firmly believes in supporting regulated research of schedule I controlled substances.” We look forward to increased research and have a dedicated psychedelic contract research organization (CRO) in Cedar Clinical Research, capable of studying promising new treatments.
Posted by AGORACOM-JC
at 5:42 PM on Monday, September 13th, 2021
If you’ve ever thought to yourself “how great would it be if my favourite comfort foods could only be healthier” than meet Boosh … an Award Winning Plant-Based Comfort Food Company whose products include:
Mac N Cheese and Peas
Veggie Bolognese
and other “Heat and Eat” delicious comfort foods that are
Multiple Award winning
100% Plant-based, GMO and Gluten Free
The company has only been a public entity for a few months and it’s already making waves.
Expanded to approximately 400 stores in less than 2 years including
Whole Foods, Safeway, Metro, IGA, Choices + many other retailers
An alliance with Beyond Meat
Distributed by UNFI – one of the largest distributors in North America
Expanded into refrigerated section with new SKUs
Growth of The Plant-Based food Market is Undeniable…
The plant-based food market is expected to grow at a CAGR of 11.9% from 2020 to 2027 to reach $74.2 billion by 2027 according to ResearchAndMarkets.com.
Watch this powerful interview with Boosh CEO Jim Pakulis.
Posted by AGORACOM
at 10:06 PM on Saturday, September 11th, 2021
Fabled Silver Gold (FCO TSXV) ( FBSGF: OTC ) controls 100% of the Santa Maria mine gold and silver property in Mexico.
It is a high grade silver gold property that is situated right in the middle of the Mexican Epithermal silver gold belt that has reportedly produced more silver than any other equivalent area in the entire planet.
To say it’s a mining friendly jurisdiction is an understatement.
Multiple major operators are in the vicinity and Santa Maria already has a silver equivalent 43-101 of 3.2m ounces, but is adding to that not only in tonnage, but in grade. High grade; and that only improves a future 43-101.
High grade mines pay back Capital costs faster, making them economic and profitable.
Check out these intercepts from the last 4 press releases that include not only high grade silver but a new gold discovery as well:
Aug 17: New Gold System, Hits Lower Feeder, which Returns 580.01 g/t Silver Eq, PLUS 19.90% Lead, 5.18% Zinc and 1.29% Copper
Aug 23rd: Intercepts Gold Bearing Sheeted Vein Structure Over A True Width of 150 Meters
Sept 1st: New High Grade Vein Breccia Outside Santa Maria Structure Boundaries, with Grades High As 1,072.73 g/t Ag Eq and..
Sept: 8th: Fabled Hits Supergene Quartz Breccia Over 1.35 Meters Grading 689.56 g/t Ag Eq
Fabled is intent on proving Santa Maria is bigger and of potentially higher grade than the market understands, and is well on its way. Grade is king an the mines with the best grade get developed first.
Santa Maria is already a proven past producer, the development progress made by Fabled is only increasing the potential re-development, but with potential better economics. Sit back and enjoy as Peter Hawley President & CEO explains the importance of how high grade intercepts improve a mines chance of being developed.
Posted by AGORACOM-JC
at 5:13 PM on Tuesday, September 7th, 2021
FOBI AI is a global leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement for enterprise level retailers.
More than just lip service, these are just a sample of the major milestones reached by $FOBI as of the end of July:
Strategic Alliance with global data leader – NeilsonIQ – to “Transform Retail Sector”
A partnership with NTT DATA, a top-ranked global IoT services company, and subsidiary of Nippon Telegraph and Telephone, the world’s 4th largest telecom company, ranked 55th In Fortune Global 500.
Approved for Oracle Partner Network
Pilot Projects with Sobeys, TELUS, Certas and other national level retailers
Multi-Year Direct Seller Agreement With TELUS, in which TELUS resells FOBI solutions to national business customers….
and so much more
But if this wasn’t enough $FOBI announced the following in the last 10 days while the rest of us were on vacation:
